Solara Active Pharma Sciences Ltd Partly Paidup
₹273.50▼ -31.30 (-10.27%)
SOLARAPP1·NSE·Healthcare
Market Cap
333.67 Cr
PE Ratio
—
Volume
111
Day High - Low
281.00 - 272.20
52W High-Low
316.60 - 272.20
₹273.50▼ -31.30 (-10.27%)
Market Cap333.67 Cr
PE Ratio—
Volume111
Day High - Low281.00 - 272.20
52W High-Low316.60 - 272.20
Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1): company summary
Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) is a micro-cap Healthcare company valued at ₹334 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) is a micro-cap Healthcare company valued at ₹334 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Solara Active Pharma Sciences Ltd Partly Paidup last traded at ₹273.5, sharply down 10.27% on the day.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹273.50 on 30 Mar 2026 (202 days ago). Not a live price.
DocStoX Score
—/10
Not scored
Fair Value
Sign in to see
ROE
—
P/E
—
Debt / Equity
—
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Insufficient data
Price performance
Day₹272.20
₹281.00
52W₹272.20
₹316.60
DocStoX take
We do not have enough data on this company to score it — only 2 of 5 measures could be assessed. Rather than publish a number built on that, we are showing none.
DocStoX score
Low confidence—
No score
Quality
No data
No profitability data
Valuation
No data
No valuation multiples
Growth
No data
No multi-year history
Risk
Moderate
₹334 cr market cap
Momentum
Weak
3% of 52-week range
Only 2 of 5 measures could be assessed — too little to score this company honestly.
At a glance
Market Cap
₹334 Cr
52W High / Low
₹317 / ₹272
Dividend Yield
—
Promoter Holding
—
EPS (TTM)
—
Book Value
—
Key highlights
- Momentum is weak (0.0/10)
- Near the bottom of its 52-week range (3%)
0 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Solara Active Pharma Sciences Ltd Partly Paidup’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Solara Active Pharma Sciences Ltd Partly Paidup peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Solara Active Pharma Sciences Ltd Partly Paidup with peers
Solara Active Pharma Sciences Ltd Partly Paidup vs Sun Pharmaceutical Industries LimitedSolara Active Pharma Sciences Ltd Partly Paidup vs Divi's Laboratories LimitedSolara Active Pharma Sciences Ltd Partly Paidup vs Torrent Pharmaceuticals LimitedSolara Active Pharma Sciences Ltd Partly Paidup vs Apollo Hospitals Enterprise LimitedSolara Active Pharma Sciences Ltd Partly Paidup vs Zydus Lifesciences LimitedSolara Active Pharma Sciences Ltd Partly Paidup vs Laurus Labs Limited
Related tools & concepts
Value Solara Active Pharma Sciences Ltd Partly Paidup with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing